Kyle M. Rose, MD

GU Oncology Now

<p>Kyle M. Rose, MD, Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center &amp; Research Institute, describes how cell-free urinary tumor DNA is used as a strategy to detect MRD prior to repeat-transurethral resection of bladder tumors in NMIBC.</p>


Detecting MRD Prior to Repeat-transurethral Resection of Bladder Tumor in NMIBC

American Society of Clinical Oncology Genitourinary Cancers Symposium 2023

ASCO GU Symposium 2023

Kyle M. Rose, MD, describes how cell-free urinary tumor DNA is used as a strategy to detect MRD prior to repeat-transurethral resection of bladder tumors.

Detecting MRD Prior to Resection of Bladder Tumor in NMIBC

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe